Hepatic and extrahepatic angiotensinogen gene expression in rats with acute nephrotic syndrome

Renal Failure

Volumn 19, Issue 3, 1997, Pages 389-399

  Ibarra Rubio, María Elena ^a   Margarita Ramos, V ^a   Correa Rotter, Ricardo ^b   Pedraza Chaverrí, José ^b  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSINOGEN; MESSENGER RNA; PUROMYCIN AMINONUCLEOSIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONGENITAL NEPHROTIC SYNDROME; CONTROLLED STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; TISSUE DISTRIBUTION; TISSUE SPECIFICITY; URINARY EXCRETION;

EID: 0030946901     PISSN: 0886022X     EISSN: None     Source Type: Journal    
DOI: 10.3109/08860229709047725     Document Type: Article

References (48)

1. Frenk S, Antonowicks I, Craig JH, Metcoff J: Experimental nephrotic syndrome induced in rats by aminonucleoside: renal lesions and body electrolyte composition. Proc Soc Exp Biol Med 89:424-427,1955.
2. Pedraza-Chaverri J, Cruz C, Ibarra-Rubio ME, Chdvez MT, Calleja C, Tapia E, Uribe MC, Romero L, Pena JC: Pathophysiology of experimental nephrotic syndrome induced by puromycin aminonucleoside in rats. I. The role of proteinuria, hypoproteinemia and renin-angiotensin-aldosterone system on the sodium retention. Rev Invest Clin 42:29-38, 1990.
3. Glassock RJ, Cohen AH, Adler SG: Primary glomerular diseases. In Brenner BM (ed), The Kidney, 5th ed. Philadelphia, W.B. Saunders, 1996, vol II, pp 1392-1497.
4. Yayama K, Konishi K, Ohta A, Takano M, Ohtani R, Itoh N, Okamoto H: Elevation of plasma angiotensinogen in rats with experimentally induced nephrosis. Nephron 63:89-93, 1993.
5. Pyo HJ, Summer SN, Niederberger M, Kirn JK, Schrier RW: Arginine-vasopressin gene expression in rats with puromycin-induced nephrotic syndrome. Am J Kidney Dis 25:58-62, 1995.
6. Ricardo SD, Bertram JF, Ryan GB: Podocyte architecture in puromycin aminonucleoside-treated rats administered tungsten or allopurinol. Exp Nephrol 3:270-279, 1995.
7. Ueda N, Baliga R, Shah S: Role of catalytic iron in an animal model of minimal change nephrotic syndrome. ATWmry to 49:370-373, 1996.
8. Bernard DB: Metabolic abnormalities in nephrotic syndrome: pathophysiology and complications. In Stein JH (ed), Contemporary Issues in Nephrology, vol 9: Nephrotic Syndrome, New York, Churchill Livingstone, 1982, pp 85-20.
9. Lewandowski AE, Liano WSL, Stinson-Fisher CA, Kenk JD, Jefferson LS: Effects of experimentally induced nephrosis on protein synthesis in rat liver. Am J Physiol 254:C634-C642, 1988.
10. Pedraza-Chaverri J, Cruz C, Châvez MT, Löpez A, Ibarra-Rubio ME, Tapia E, Pena JC: Pathophysiology of experimental nephrotic syndrome induced by puromycin aminonucleoside in rats. II. In vitro release of renin, angiotensinogen, and aldosterone. Rev Invest din 42:120-126, 1990.
11. Pedraza-Chaverri J, Cruz C, Ibarra-Rubio ME, Hemândez C, Tapia E, Pena JC: Urinary excretion of renin and angiotensinogen in nephrotic rats. Nephron 57:106-108, 1991.
12. Arévalo AE, Ibarra-Rubio ME, Cruz C, Pena JC, Pedraza-Chaverri J: Angiotensin I converting enzyme activity in puromycin aminonucleoside-nephrotic syndrome. Clin Chim Acta 191:175-184, 1990.
13. Ohkubo H, Nakayama K, Tanaka T, Nakanishi S: Tissue distribution of rat angiotensinogen mRNA and structural analysis of its heterogeneity. J Biol Chem 261:319-323, 1986.
14. Campbell DJ, Habener JF: Angiotensinogen gene is expressed and differentially regulated in multiple tissues of the rat. J Clin Invest 78:31-39, 1986.
15. Richoux JP, Cordonnier JL, Bouhnik J, Clauser E, Corvol P, Menard J, et a): Immunocytochemical localization of angiotensinogen in rat liver and kidney. Cell Tissue Res 233:439-451, 1983.
16. Kunapuli SP, Kumar A: Molecular cloning of human angiotensinogen cDNA and evidence for the presence of its mRNA in rat heart. Circ Res 60:786-790, 1987.
17. Lindpaintner K, Ganten D: The cardiac renin-angiotensin system: an appraisal of present experimental and clinical evidence. Circ Res 68:905-921, 1991.
18. Lynch KR, Hawelu-Johnson CL, Guyenet PG: Localization of brain angiotensinogen mRNA by hybridization histochemistry. Mol Brain Res 2:149-158, 1987.
19. Genain CP, Van Loon GR, Kotchen TA: Distribution of renin activity and angiotensinogen in rat brain: effects of dietary sodium chloride intake on brain renin. J Clin Invest 76:1939-1945, 1985.
20. Ganten D, Schelling P, Vecsei P, Ganten U: Iso-renin extrarenal origin: the tissue angiotensinogenase systems. Am J Med 60:760-772, 1976.
21. Dzau VJ: Circulating versus local renin-angiotensin system in cardiovascular homeostasis. Circulation 77:14-113,1988.
22. Mendelsohn FSO: Angiotensin II: evidence for its role as an intrarenal hormone. Kidney Int 22:S78-S81, 1982.
23. Schunkert H, Ingelfinger JR, Dzau VJ: Evolving concepts of intrarenal renin-angiotensin system in health and disease: contributions of molecular biology. Renal Physiol Biochem 14:146-154, 1991.
24. Mulrow PJ: Adrenal renin: a possible local regulator of aldosterone production. Yale J Biol Med 62:503-510, 1989.
25. Ganong WF: The brain angiotensin system. Anna Rev Physiol 46:17-31, 1984.
26. Kunapuli SP, Benedict CR, Kumar A: Tissue specific hormonal regulation of the rat angiotensinogen gene expression. Arch Biochem Biophys 254:642-646, 1987.
27. Ingelfinger JR, Pratt RE, Ellison KE, Dzau VJ: Sodium regulation of angiotensinogen mRNA expression in rat kidney cortex and medulla. J Clin Invest 78:1311-1315, 1986.
28. Gömez RA, Cassis L, Lynch KR, Chevalier RL, Wilfong N, Carey RM, Peach MJ: Fetal expression of the angiotensinogen gene. Endocrinology 123:2298-2302, 1988.
29. Keuneke C, Yacullo R, Sugiura, Mall G, Metzeger R, Ganten D: Converting enzyme inhibitors differentially affect expression of genes of the renin angiotensin system. Clin Exp Hypenens 17:551-574, 1995.
30. Ibarra-Rubio ME, Pedraza-Chaverri J, Panduro A: Differential regulation in the expression of hepatic genes in nephrotic and pair-fed rats. Nephron 65:119-124, 1993.
31. Thabet MA, Challa A, Chan W, Liu F, Hintz RL, Chan JCM: Insulin like growth factor and growth hormone receptor in nephrotic rats. Am J Physiol 266:E102-E106, 1994.
32. Iwao H, Fukui K, Kim S, Nakayama K, Ohkubo H, Nakanishi S, Youichi A: Sodium balance effects on renin, angiotensinogen, and atrial natriuretic polypeptide mRNA levels. Am J Physiol 255:EI29-E136, 1988.
33. Rosenberg ME, Chimielewski D, Hosteller TH: Effect of dietary protein on rat renin and angiotensinogen gene expression. J Clin Invest 85:1144-1149, 1990.
34. Lowry OH, Rosenbrought NJ, Fair AL, Randall RJ: Protein determination with the Polin phenol reagent. J Biol Chem 193:265-272, 1951.
35. Pedraza-Chaverri J, Zúñiga-Estarda A, Ibarra-Rubio ME, Cruz C, Tapia E, Peña JC: Productión de anticuerpos policlonales para la cuantificaciön del decapéptido angiotensina I por radioinmunoanalisis. Rev Invest Clin 40:365-377, 1988.
36. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium-thiocyanate-phenolchloroform extraction. Anal Biochem 162:156-159, 1987.
37. Lynch KR, Simnad VI, Ben-Ari ET, Garrison JC: Localization of preangiotensinogen messenger RNA sequences in the rat brain. Hypertension 8:540-543, 1986.
38. Everett AD, Scott J, Wilfong N, Marino B, Rosenkranz RP, Inagami T, Gez RA: Renin and angiotensinogen expression during the evolution of diabetes. Hypertension 19:70-78, 1992.
39. Liang KH, Oveisi F, Vaziri ND: Gene expression of hepatic cholesterol 7-alpha-hydroxylase in the course of puromycin-induced nephrosis. Kidney Int 49:855-860, 1996.
40. Yamauchi A, Imai E, Noguchi T, Tanaka T, Yamamoto S, Mikami H, Fukuhara Y, Fuji M, Orita Y, Kamada T: Albumin gene transcription is enhanced in liver of nephrotic rats. Am J Physiol 254:E676-E679,1989.
41. Pedraza-Chaverrf J, Huberman A: Actinomycin D blocks the hepatic functional albumin mRNA increase in aminonucleoside nephrotic rats. Nephron 59:648-650, 1991.
42. Lewandowski AE, Liao WSL, Stinson-Fisher CA, Kenk JD, Jefferson LS: Effects of experimentally induced nephrosis on protein synthesis in rat liver. Am J Physiol 254:C634-C642, 1988.
43. Tarugi P, Calanmdra S, Chan L: Changes in apolipoprotein AI mRNA level in the liver of rats with nephrotic syndrome. Biochim Biophys Acta 686:51-61, 1986.
44. Panduro A, Castrillon L, Pedraza-Chaverrf J, Vargas F, Ibarra-Rubio ME: Regulation of apolipoprotein A-l and E gene expression in liver and intestine of nephrotic and pair-fed rats. Nephron 65:100-107, 1993.
45. Vaziri ND, Liang KH: Hepatic HMG-CoA reductase gene expression during the course of puromycininduced nephrosis. Kidney Int 48:1979-1985,1995.
46. Correa-Rotter R, Hosteller TH, Rosenberg ME: Renin and angiotensinogen gene expression in experimental diabetes mellitus. Kidney Int 41:796-804, 1992.
47. Pratt RE, Zou WM, Naftilan AJ, Ingelfinger JR, Dzau VJ: Altered sodium regulation of renal angiotensinogen mRNA in the spontaneously hypertensive rat. Am J Physiol 256:F469-F474, 1989.
48. Cassis LA, Saye JA, Peach MJ: Location and regulation of rat angiotensinogen messenger RNA. Hypertension 11:591-596, 1988.